The effects of monensin on cells infected with pseudorabies virus have been studied. Treatment with monensin (1 ~tM) prevented the secretion of the 89K pseudorabies virus-induced sulphated glycoprotein. A polypeptide with a mol. wt. of 78K was secreted into the medium from monensin-treated BSC-1 cells. Mannose labelling showed that initial glycosylation proceeded normally in the presence of monensin, although the absence of fucose label revealed that the later stages in processing were blocked. No intracellular accumulation of virus-induced proteins was found in monensin-treated cells. Infectivity assays, measurement of thymidine-labelled particles and electron microscopy showed that monensin blocked the release of virus particles from cells, although viral morphogenesis was unaffected.
INTRODUCTION
Monensin belongs to the class of compounds called ionophores which transport ions across biological membranes. Monensin has a predilection for Na ÷ ions (Pressman, 1968 (Pressman, , 1976 .
Monensin has been shown to inhibit the release of Sindbis and vesicular stomatitis viruses (Johnson & Schlesinger, 1980) , herpes simplex virus type 1 (Johnson & Spear, 1982) , vaccinia virus (Payne & Kristensson, 1982) , Semliki Forest virus (Griffiths et al., 1983) and La Crosse virus (Cash, 1982) .
The appearance at the cell surface of the glycoproteins of the above viruses was inhibited by mortensin (see also K~i/iri/iinen et al., 1980) , although their processing was affected in different ways. Prior to the addition of terminal sugars, a number of mannose residues are removed from the oligosaccharide chains (Hunt et al., 1978; Tabas et al., 1978) . With the G protein of vesicular stomatitis virus, cleavage of mannose proceeded normally whereas with the glycoproteins of Sindbis virus, this step was inhibited (Johnson & Schlesinger, 1980) . In La Crosse virus-infected cells monensin caused accumulation of a glycoprotein which was partially processed (Madoff & Lenard, 1982) .
We have studied the effects of monensin on pseudorabies virus-infected BSC-1 cells. Cells infected with this virus excrete large amounts of a sulphated glycoprotein with a molecular weight of 89 000 (Pennington & McCrae, 1977) . This protein is virus-specified and does not comigrate with any of the major intracellular polypeptides. Our work was carried out to investigate the possibility that monensin would interfere with the glycosylation and secretion of the 89K glycoprotein, and the assembly and release of virus particles.
METHODS

Cells.
BSC-1 cells were maintained as monolayers in Eagle's MEM, supplemented with 5% NaHCO3, nonessential amino acids, L-glutamine, crystamycin and 10~ newborn calf serum. For experiments, the cells were seeded on to 30 mm plastic Petri dishes at approximately 106 cells/dish.
Virus. A cloned stock of the Kaplan strain of pseudorabies virus (supplied by C. R. Pringle, University of Warwick, Coventry, U.K.) was grown in BSC-1 ceils and subsequently stored at -70 °C. Cells were infected at a multiplicity of infection of about 10 p.f.u./ceU.
Chemicals. Monensin (Calbiochem) was dissolved in absolute ethanol to give a concentration of 100 ~tM. Tunicamycin (Sigma) was dissolved in distilled water to give a concentration of 500 ~tg/ml. These formed stock 0022-1317/84/0000-5840 $02.00 © 1984 SGM Infectivity assay. Monolayers of BSC-1 ceils (106 cells per 30 mm dish) were infected with pseudorabies virus at about 10 p.f.u./cell. After 1 h adsorption the cells were rinsed three times with growth medium to remove any residual virus from the cell surface. The cells were incubated for 24 h in the presence of 1 ~tM-monensin, cytosine arabinoside (25 ~tg/ml) or 1% ethanol. The medium from each plate was serially diluted and 0-2 ml amounts were added to the BSC-1 monolayers. After I h adsorption the inocula were removed and the cells overlaid with growth medium containing 0-9% agar. After 4 days the cells were fixed in 10% formalin for 1-5 h and stained with 10% Giemsa for 5 min, after the removal of the agar overlay.
Assay of virus particles. Monolayers of BSC-1 ceils (106 cells per 30 min dish) were infected as for the infectivity assay. The cells were labelled with [3H]thymidine at 20 ~tCi/ml from 4 to 24 h post-infection. The medium from each plate was centrifuged at 500 g to remove cellular debris, layered onto a sucrose gradient (10 to 50%, w/v in phosphate-buffered saline), and centrifuged at 65000g for 1 h in a 3 x 25 ml swing-out rotor. Fractions were collected, spotted onto 1 cm 2 filter papers, washed six times in 10% TCA and once in absolute ethanol. The filter papers were placed in vials containing toluene/PPO and counted in a Packard Tri-Carb 300 counter.
RESULTS
Polypeptides from pseudorabies virus-infected cells
The effect of monensin treatment on virus-induced polypeptide synthesis was investigated. Monensin did not cause any major differences in the intracellular polypeptide profile of either uninfected or infected cells (Fig. 1 , compare lanes 1 with 2, and 3 with 4). Lane 5 shows the major secreted polypeptide of 89000 molecular weight described by Pennington & McCrae (1977) . This polypeptide was not associated with virus particles, as it remained in the supernatant after centrifugation at 80000 g for 3 h (result not shown). Furthermore, it did not co-migrate with any of the major intracellular polypeptides (compare lane 5 with 3 and 4). Monensin treatment resulted in a large decrease in the amount of polypeptide 89K released into the medium (lane 6). Analysis by densitometry revealed that the decrease was about 97~o. A new protein with a molecular weight of 78000 was found after monensin treatment (lane 6); the quantity of this polypeptide was only about 9 ~o of polypeptide 89K found in the medium of untreated cells (as shown by densitometry). Comparison of lane 3 with 4 shows that there was no accumulation within the cell of polypeptide 89K or 78K, nor of any other polypeptides which might be precursors. A number of proteins were released from uninfected cells (lane 7); after monensin treatment there was a decrease in the secretion of most of these (data not shown).
Lower concentrations of monensin in the medium (0.05 and 0.1 ~ti) had no effect on polypeptide 89K. At 0-5 p.M, monensin produced an identical result to that described above. Higher concentrations of 5 and 10 ~tM failed to elicit any major differences in the intracellular polypeptides, nor were the effects on polypeptide 89K any more pronounced (data not shown). 89 000 (lane 1) was absent in the presence of monensin (lane 2). Lane 4 shows that mannose was also incorporated into the 78K protein released from the monensin-treated cells. The 89K polypeptide (lane 3) appears to co-migrate with the cellular 89K species in lane 1. It is worth noting that this polypeptide is absent from both the ceils and the medium in the presence of monensin.
Effect of monensin on glycosylation
The results of labelling with [3 H]fucose are given in Fig. 3 (a, b) . In the presence of monensin there was a substantial decrease in fucose incorporation (Fig. 3 a, lane 2) ; two faint bands, with molecular weights of 105K and 78K, could be detected. Fig. 3(b) , lane 2 shows that fucose was not incorporated into the 78K polypeptide secreted from monensin-treated cells. The broad band, with 72K tool. wt., was also observed in the medium from uninfected cells and is, therefore, most likely a host protein.
Effect of tunicamycin
Since tunicamycin is a known inhibitor of glycosylation, it was of interest to compare and contrast its effect with that of monensin. When the cells were labelled with [3H]leucine, tunicamycin caused no major differences in the intracellular polypeptide profiles (Fig. 4a) . Apart from the single marked band (h), the polypeptides are virus-induced. The effect of tunicamycin on the 89K secreted protein was similar to that of monensin. A new protein, molecular weight 78K, was found in the medium (Fig. 4b, lane 2) . The 78K species from tunicamycin-and moncnsin-treated cells co-migrated when run on the same gel (data not shown). Unlike the result with monensin, there was no trace of any protein in the 89K region and the amount of 78K in the medium was considerably greater. Neither the intracellular nor the secreted polypeptides were labelled with mannose or fucose in the presence of tunicamycin (data not shown).
Release of virus
We studied the release of pseudorabies virus particles from BSC-1 cells using three different methods: infectivity assay, release of [3 H]thymidine-labelled particles and electron microscopy. All three methods produced results leading to the same conclusion: monensin inhibits the release of pseudorabies virus from the cells.
Monensin caused a decrease in the amount of infectious virus in the extracellular medium which varied from 17-to 40-fold in different experiments (results not shown). Sucrose density 3 gradient centrifugation of [ H]thymidine-labelled particles released from cells (Fig. 5 ) also showed that monensin inhibited virus release from ceils. The peak at fraction 17 did not contain any virus particles upon electron microscopic examination; virus was found in the peak at fraction 5. The drop in the amount of radioactivity in this peak which followed monensin treatment was of the same order of magnitude as the decrease in extracellular virus titre.
Thin sections of pseudorabies virus-treated cells were examined by electron microscopy. In the untreated cells, particles could be seen around the outside of the cell (Fig. 6a) . A small number of these particles were microvilli in transverse section; however, higher magnification pictures revealed that most of the particles were virions (Fig. 6b) . After monensin treatment very few virus particles were observed in association with the external cell surface (Fig. 7 a) . The usual effects of monensin treatment, i.e. dilated vacuoles and condensed mitochondria, can be seen.
There was no obvious accumulation of virus particles inside the monensin-treated cells. 
Viral morphogenesis
This proceeded normally in the presence of monensin. Fig. 7 (c) shows a group of enveloped virions at the nuclear membrane; there is also a naked nucleocapsid inside the nucleus. Further evidence was provided by infectivity data: monensin did not cause any decrease in the production of intracellular infectious virus (results not shown).
DISCUSSION
Our results indicate that monensin affects the processing and secretion of the 89K polypeptide. It also affects the processing of intracellular virus-induced glycoproteins, and exerts an inhibitory effect on the release of virions from cells.
Monensin has been shown to inhibit the release of a number of viruses (see Introduction). Our results agree with these findings. The results from the infectivity and [3H]thymidine experiments gave about the same reduction in the amount of extracellular virus. A similar result was found when the cells were examined by electron microscopy.
We did not find any obvious accumulation of virions inside the monensin-treated cells. In any event, it would be difficult to detect such a phenomenon because vacuoles containing virions (a) were regularly seen in the normal course of infection. However, if the particulate matter in some of the vacuoles represents degraded virus [as suggested by Johnson & Spear (1982) ], it may be that virus accumulates, and is subsequently degraded. The infectivity data would support this conclusion, as there was no increase in the intracellular titre. However, any accumulation of non-infectious virions would not be detected by the infectivity assay. The finding that monensin treatment partially inhibited the secretion of virus-induced protein was not unexpected, as the compound has been shown to inhibit the secretion of a number of proteins, including fibronectin (Tartakoff & Vassalli, 1978) , immunoglobulins (Tartakoff & Vassalli, 1977) and acetylcholinesterase (Smilowitz, 1980) . An explanation of the increased mobility in gels of the secreted protein was sought in the known effects of monensin on glycosylation. The general inhibitory effect on fucose labelling exerted by monensin indicated that monensin probably inhibited the addition of terminal sugars to the oligosaccharide chains on virus glycoproteins. An overall effect similar to that exerted by tunicamycin, which blocks the first stage of glycosylation, the addition of N-acetylglucosamine (Tkacz & Lampen, 1975; Lehle & Tanner, 1976) and subsequent glycosylation steps, could be produced if, in addition to inhibiting the addition of terminal sugars, monensin allowed the removal of mannose residues. Mannose removal from the G protein of vesicular stomatitis virus occurred in the presence of monensin (Johnson & Schlesinger, 1980) . The finding that the secreted proteins produced in the presence of monensin and tunicamycin had increased mobilities and co-migrated lent support to the hypothesis that their apparent reduction in size was due to the inhibitory effects on glycosylation described above. Effects due to inhibition of Olinked glycosylation were not studied. Johnson & Spear (1982) working with herpes simplex virus have suggested that monensin blocks this type of glycosylation, unlike tunicamycin, which does not Schida & Dales, 1981) . It is not known whether any pseudorabies virus glycoproteins contain O-linked oligosaccharides. Mannose removal during the processing of virus glycoproteins is affected to different degrees in different systems. The finding that three intracellular proteins were more intensely labelled with mannose after monensin treatment, and that two new polypeptides were detected under these conditions may therefore be due to an inhibitory effect of monensin on mannose removal. Monensin has been shown to exert such an effect on the processing of herpes simplex virus type 1 glycoproteins gA and pgC, causing them to accumulate with high-mannose oligosaccharides (Wenske et al., 1982) . 
